Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Link Therapeutics Logo
Link Therapeutics Growth Score
89
CB Rank
93903
Heat Score
74
Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Founded
obfuscation
PrivateSeries B Kyoto, Kyoto, Japan1-10 www.link-therapeutics.com/
Emergency Medicine
Medical
Pharmaceutical
Overview

Link Therapeutics
Total Funding
obfuscation
Growth Score
89
Heat Score
74

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score89
-2 pts
in past quarter
Heat Score 74
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Link Therapeutics

CB Rank
93903
Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Founded
obfuscation
PrivateSeries B Kyoto, Kyoto, Japan1-10 www.link-therapeutics.com/
Emergency Medicine
Medical
Pharmaceutical

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Link Therapeutics Inc.
Also Known As リンクセラピューティクス
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Therapeutic Methods for Targeting Autoantibodies
Development of treatments aimed at removing pathogenic autoantibodies and their producing cells to address autoimmune diseases.
Pathogenic Autoantibody Identification
Techniques and research focused on discovering and characterizing disease-causing autoantibodies in patients.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B
obfuscation
Series B - Link Therapeutics Logo
Series B - Link Therapeutics
5
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Apr 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Link Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

3The intellectual property of Link Therapeutics includes 3 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Link Therapeutics's headquarters? Link Therapeutics is located in Kyoto, Kyoto, Japan.Who invested in Link Therapeutics? Link Therapeutics has 5 investors including Kyoto University Innovation Capital and  ITOCHU Technology Ventures.When was the last funding round for Link Therapeutics? Link Therapeutics closed its last funding round on
obfuscation
from a Series B round.Who are Link Therapeutics's competitors? Alternatives and possible competitors to Link Therapeutics may include Orna Therapeutics, Amylyx Pharmaceuticals, and  argenx.How much funding has Link Therapeutics raised to date? Link Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|